CH CRL (R4)
0.9.0 - Draft
This page is part of the CH CRL (R4) (v0.9.0: STU Draft) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="nkrs-cogstaging"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-cogstaging defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">I<a name="nkrs-cogstaging-I"> </a></td><td>Stage I</td><td>Limited to kidney, not ruptured, no residual tumor.</td></tr><tr><td style="white-space:nowrap">II<a name="nkrs-cogstaging-II"> </a></td><td>Stage II</td><td>Extends beyond the kidney but is completely excised.</td></tr><tr><td style="white-space:nowrap">III<a name="nkrs-cogstaging-III"> </a></td><td>Stage III</td><td>Residual tumor confined to the abdomen. Micro/macroscopic remains of a tumour.</td></tr><tr><td style="white-space:nowrap">IV<a name="nkrs-cogstaging-IV"> </a></td><td>Stage IV</td><td>Hematogenous / distant lymph nodes metastases.</td></tr><tr><td style="white-space:nowrap">V<a name="nkrs-cogstaging-V"> </a></td><td>Stage V</td><td>Bilateral renal involvement at diagnosis.</td></tr></table></div>
</text>
<url value="http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-cogstaging"/>
<version value="0.9.0"/>
<name value="NkrsCOGStaging"/>
<title value="NKRS - COG Staging"/>
<status value="active"/>
<date value="2022-02-04T14:14:21+01:00"/>
<publisher value="Bundesamt für Gesundheit BAG"/>
<contact>
<name value="Bundesamt für Gesundheit BAG"/>
<telecom>
<system value="url"/>
<value value="https://www.bag.admin.ch/"/>
</telecom>
</contact>
<description
value="This data item records staging of Wilms’ tumour for pediatric patients acc. to pre-chemotherapy staging
system developed by the National Wilms’ Tumor Study Group (NWTSG). Based exclusively on the anatomic extent of the
tumour, without consideration of genetic, biologic, or molecular markers.
**COG staging (Variable number: 4.19)**
in \'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)\'
([EN](https://www.nacr.ch/assets/files/uploads/a-datadictionary-basicvariables-v1.1.pdf),
[DE](https://www.nkrs.ch/assets/files/uploads/a-datenstruktur-variablen-der-basisdaten-v1.1.pdf),
[FR](https://www.onec.ch/assets/files/uploads/a-dict-des-donnees-variables-de-base-v1.1.pdf),
[IT](https://www.snrt.ch/assets/files/uploads/a-dati-oncologici-variabili-di-base-v1.1.pdf))"/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CH"/>
</coding>
</jurisdiction>
<copyright value="CC-BY-SA-4.0"/>
<caseSensitive value="true"/>
<valueSet value="http://fhir.ch/ig/ch-crl/ValueSet/nkrs-cogstaging"/>
<content value="complete"/>
<count value="5"/>
<concept>
<code value="I"/>
<display value="Stage I"/>
<definition value="Limited to kidney, not ruptured, no residual tumor."/>
</concept>
<concept>
<code value="II"/>
<display value="Stage II"/>
<definition value="Extends beyond the kidney but is completely excised."/>
</concept>
<concept>
<code value="III"/>
<display value="Stage III"/>
<definition
value="Residual tumor confined to the abdomen. Micro/macroscopic remains of a tumour."/>
</concept>
<concept>
<code value="IV"/>
<display value="Stage IV"/>
<definition value="Hematogenous / distant lymph nodes metastases."/>
</concept>
<concept>
<code value="V"/>
<display value="Stage V"/>
<definition value="Bilateral renal involvement at diagnosis."/>
</concept>
</CodeSystem>